Internal Medicine

Low levels of COC associated with a higher likelihood of outpatient flares that required corticosteroids, hospitalizations, and surgical interventions.

Favorable neurologic function was slightly higher in a tranexamic acid group than patients taking a placebo.

Lanthanum is commonly prescribed to CKD patients to help reduce the risk of bone and cardiovascular disease.

There are currently no FDA-approved treatments for eosinophilic esophagitis.

Despite not being able to attend conferences live, there are some advantages to a virtual conference.

The biologic drug is set to be used as a combination therapy for asthma.

Patients saw improvement in symptom perception, activity limitation, emotional function, and environmental stimuli.

It has been approximately 60 years since a new treatment for coughs has come on the market.

Problems using inhalers correctly is an ongoing issue for both pediatric and adult patients.

The new drug allows for flexible dosing so as to address individual patient needs.

In a new study presented at ERS 2020, Dr. Mark Levy discusses how a digital inhaler reduces the amount of people who use their inhaler incorrectly.

This article is the first in a series of 4 articles exploring the epidemic of liver disease called nonalcoholic fatty liver disease and its more severe form, nonalcoholic steatohepatitis.

Countries, including the USA, have shown a stagnation or a small increase of deaths linked to NCDs.

At recommended adherence rates, automatic AI screening technology for diabetic retinopathy is a preferred strategy over conventional eye care professional screening.

In a poster presented at ERS, researchers find the complement and coagulation cascades pathway was up-regulated in response to airway presence of Moraxella genera that might suggest an activation of systemic innate immunity in response to Moraxella.

Three patients with unclassified interstitial lung disease had a change in diagnosis during the study’s follow-up period.

Azacytidine 300 mg tablets, CC-486 is earmarked for AML patients who achieved their first complete remission following intensive induction chemotherapy.

Investigators report on a post-hoc analysis of the EMPA-REG OUTCOME trial that assesses the efficacy of the SGLT-2 inhibitor in patients with obstructive sleep apnea.

These guidelines set by ESC and EAS 2019 established treatment goals for LDL-C, non-HDL-C, and Apo-B in patients at high risk for cardiovascular disease.

The new equation model has shown to be more accurate than the Framingham Lifetime Risk equation and Pooled Cohort Equation.

Post hoc analysis of REAL-CAD shows the cholesterol metric does not serve to inform statin treatment control of coronary artery disease.

New data shows that high BMI individuals who were in the lowest polygenic score quintile had a 5-fold greater risk of diabetes than those with low BMI and a high polygenic score.

According to late breaking data, younger women exhibit a decreased risk for heart attack mortality due to estrogen’s protective effect

Evolocumab and alirocumab produced LDL-C reduction in patients regardless of underlying mutations, investigators reported.